Chimerix Inc. (NASDAQ:CMRX) changes shares on Tuesday trading session, with a change of 6.37% or $0.2 shares. The trading starts at $3.14 and closed at $3.14 throughout the day. The trading session low price was $3.14 and day high was $3.52 on Tuesday, August 04. After the session, the Healthcare sector daily volume shifted to 0.51 million while its average volume is 647.96K. In other hand, the CMRX market cap reached to $214.16M.
On May 7, 2020, BRIEF-Chimerix Reports Q1 Loss Per Share $0.17. According to the news reported on Reuters, * CHIMERIX REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES OPERATIONAL UPDATE
Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is up 2.45% and up 4.05% for month. Its quarterly performance was 42.74% above, while its half year performance is up 85.56%. CMRX yearly performance stood at positive 14.38% and rise 64.53% for year-to-date. Current recommendation for Chimerix Inc. is 2.30.
Earnings per share or EPS is an important financial measure, which defines the profitability of a company. CMRX EPS (TTM) for 12-month is -1.83. EPS for this year is -41.90%, while for the next year its value is -0.25. Its EPS Q/Q reached 51.50%. It has an EPS of -2.40% down for past five years.
Let’s take a look on the analyst recommendations on CMRX for the current month and previous month. For the current month, 2 of 3 analysts recommend stock as Buy while 0 as Sell, 0 as overweight, 0 as underweight and 1 as Hold. As compared with the previous month ratings, 0 analysts participate in stock recommendation. Out of 0, 0 rated it sell, 0 rated it as Buy and 0 as Hold Ratings. On the other hand, target price ranges from $3.00 – $10.00. Average target price for CMRX was reached at $6.67.
Blackrock Inc., Renaissance Technologies, LLC and Vanguard Group, Inc. (The) are the top three holders in Chimerix Inc. (CMRX) stock. On Mar 30, 2020, Blackrock Inc. has 3.97 million shares which valued 5.71 million. On Mar 30, 2020, Renaissance Technologies, LLC owned 3.25 million shares which valued at 4.68 million. On Mar 30, 2020, Vanguard Group, Inc. (The) has a total of 2.47 million shares which valued at 3.56 million. In the end, Vanguard Group, Inc. (The) have 3.99% shares outstanding of Chimerix Inc. (CMRX) on Mar 30, 2020. The insider ownership moved to 1.10% and institutional holding shifted to 54.10%.
The company posted an EPS (TTM) of -1.83. According to the most recent quarter report on (Jun 2020), 3 analysts estimated an average EPS of -0.17, while -0.35 EPS posted a year ago period. Analyst Estimated EPS for CMRX published in the report was -$0.19 – -$0.16 during the same period. Comparing with last year, the average estimated EPS was -0.35 which is lower than -0.17 which was posted for recent quarter EPS.
A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for CMRX rise 50.37% for period of 200 days. SMA for 50 days was 3.57% which is showing green signal, while SMA-20 was 1.32%. The moving average value for Chimerix Inc. (CMRX) is 994.04k and 2.02% for 200 and 50 days respectively.
Let’s take a look on the insider transactions, in which multiple shareholders are showing interest in CMRX stock. On Mar 16, Andriole Michael T., Chief Business Officer, bought 33,300 trading shares at the cost of $1.43, which valued at 47522.0. On Mar 12, MIDDLETON FRED A, Director, bought 50,000 shares at the cost of $1.40, with total shares of 197,523. On Mar 12, Sherman Michael A., Chief Executive Officer, bought 72,995 shares at the cost of 1.45. After this transaction, Sherman Michael A. total shares reached to 102,995 which valued at 0.11 million.